Este sitio requiere JavaScript habilitado para funcionar correctamente. Modifique su configuración o utilice otro navegador para continuar.

      

Esta usted abandonando la página de GSK.

El enlace le llevará a una página mantenida por un tercero, que es el único responsable de su contenido. GSK no controla, no influencia ni aprueba el sitio. Opiniones, quejas o comentarios expresados en este sitio no deben atribuirse a GSK.

Aceptar

Cancelar

PATIENT PROFILE: AMY

Medical History

  • SLE diagnosed 5 years ago
  • Worsening fatigue

Manifestations

  • Fatigue has become more severe in the past 6 months
  • Persistent myositis for the last 8 months
  • Inflammatory malar rash for the last 6 months

Recent Clinical Assessment

Medications

  • Hydroxychloroquine 400 mg/day for 5 years
  • Prednisone:
    • Prescribed 5 mg/day for 4 years
    • Dose was escalated to 15 mg/day for her last flare

Impact on Daily Living

  • Has had to find a new part-time job in order to cope with increasing fatigue
  • Can’t see her friends often due to extra rest required in the evening
  • Myositis is preventing her from playing tennis
  • The lack of exercise and increasing isolation is impacting her self-esteem and quality of life

Learn More About Other SLE Patients

What Next?

Click here to learn more about efficacy of BENLYSTA once-weekly subcutaneous injection

Additional Resources

How do I identify eligible patients in my practice?

*SELENA-SLEDAI (Safety of Estrogens in Lupus Erythematosus: National Assessment version of the Systemic Lupus Erythematosus Disease Activity Index) assesses 24 weighted variables to indicate overall disease severity.
FACIT, functional assessment of chronic illness therapy.

This patient is for illustrative purposes only and is not a real patient.